Cargando…

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome

BACKGROUND: We designed a prospective and randomized trial of mizoribine (MZR) therapy combined with prednisolone (PSL) for idiopathic membranous nephropathy (IMN) with steroid-resistant nephrotic syndrome (SRNS). METHODS: Patients with IMN were divided into 2 groups, and MZR combined with PSL was a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saito, Takao, Iwano, Masayuki, Matsumoto, Koichi, Mitarai, Tetsuya, Yokoyama, Hitoshi, Yorioka, Noriaki, Nishi, Shinichi, Yoshimura, Ashio, Sato, Hiroshi, Ogahara, Satoru, Sasatomi, Yoshie, Kataoka, Yasufumi, Ueda, Shiro, Koyama, Akio, Maruyama, Shoichi, Nangaku, Masaomi, Imai, Enyu, Matsuo, Seiichi, Tomino, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698362/ https://www.ncbi.nlm.nih.gov/pubmed/27783276 http://dx.doi.org/10.1007/s10157-016-1340-2

Ejemplares similares

Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial
por: Saito, Takao, et al.
Publicado: (2013)

Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)
por: Hama, Taketsugu, et al.
Publicado: (2018)

Mizoribine: A New Approach in the Treatment of Renal Disease
por: Kawasaki, Yukihiko
Publicado: (2009)

Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine
por: Nishikawa, Sho, et al.
Publicado: (2022)

Methylprednisolone pulse therapy combined with mizoribine following tonsillectomy for immunoglobulin A nephropathy: clinical remission rate, steroid sparing effect, and maintenance of renal function
por: Kaneko, Tomohiro, et al.
Publicado: (2010)

Involvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics
por: Murakami, Teruo, et al.
Publicado: (2012)

Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine
por: Kaneko, Tomohiro, et al.
Publicado: (2015)

The Immunosuppressive Agent Mizoribine Monophosphate Is an Inhibitor of the Human RNA Capping Enzyme
por: Picard-Jean, Frédéric, et al.
Publicado: (2013)

Evaluation of Mizoribine as an Immunosuppressant in Subrenal Capsule Assay Using Immunocompetent Mice
por: Chen, Dong‐Yi, et al.
Publicado: (1990)

IgG4-Related Tubulointerstitial Nephritis Associated with Membranous Nephropathy in Two Patients: Remission after Administering a Combination of Steroid and Mizoribine
por: Miyata, Kana N., et al.
Publicado: (2014)

Successful Treatment of Adult IgA Nephropathy with Nephrotic-Level Proteinuria by Combination Therapy Including Long-Term Coadministration of Mizoribine
por: Okonogi, Hideo, et al.
Publicado: (2012)

Efficacy and Safety of Mizoribine for the Treatment of Refractory Nephrotic Syndrome: Protocol for a Multicenter, Controlled, Open-label, Randomized Controlled Trial
por: Dong, Zheyi, et al.
Publicado: (2023)

In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus
por: Li, Shi-Fang, et al.
Publicado: (2019)

Mizoribine treatment in an elderly diabetic patient with antisynthetase-associated interstitial lung disease
por: Nagai, Kei, et al.
Publicado: (2020)

Nitazoxanide protects cats from feline calicivirus infection and acts synergistically with mizoribine in vitro
por: Cui, Zhanding, et al.
Publicado: (2020)

Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young rats
por: Kim, Ji Hong, et al.
Publicado: (2016)

Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus
por: Saijo, Masayuki, et al.
Publicado: (2005)

The Efficacy of Mizoribine (Inosine Monophosphate Dehydrogenase Inhibitor) for ANCA-Associated Vasculitis with Hepatitis B Virus Carrier
por: Muratsu, Jun, et al.
Publicado: (2012)

Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show a reduced or insufficient response to infliximab
por: Horikoshi, Masanobu, et al.
Publicado: (2009)

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
por: Hirai, Keiji, et al.
Publicado: (2017)

Comparison of Treatment Effect and Tolerance of the Topical Application of Mizoribine and Cyclosporine A in a Mouse Dry Eye Model
por: Lin, Xiang, et al.
Publicado: (2020)

Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study
por: Ayano, Masahiro, et al.
Publicado: (2022)

The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis
por: Chen, Jie, et al.
Publicado: (2022)

Mizoribine Ameliorates Renal Injury and Hypertension along with the Attenuation of Renal Caspase-1 Expression in Aldosterone-Salt-Treated Rats
por: Doi, Toshiki, et al.
Publicado: (2014)

Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease
por: Takahashi, Kei, et al.
Publicado: (2011)

Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies
por: Ikeda, Keigo, et al.
Publicado: (2017)

Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-up
por: Yagi, Nobuyuki, et al.
Publicado: (2014)

Mizoribine as a safe and effective combined maintenance therapy with prednisolone for anti-neutrophil cytoplasmic antibody-associated vasculitis in a hemodialysis patient
por: Nakamura, Gen, et al.
Publicado: (2013)

Prediction of steroid resistance and steroid dependence in nephrotic syndrome children
por: Zaorska, Katarzyna, et al.
Publicado: (2021)

A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome
por: Muso, Eri, et al.
Publicado: (2015)

Cyclosporine A and steroid therapy in childhood steroid-resistant nephrotic syndrome
por: Tahar, Gargah, et al.
Publicado: (2010)

Conversion from mycophenolate mofetil to mizoribine in the early stages of BK polyomavirus infection could improve kidney allograft prognosis: a single-center study from China
por: Li, Ping, et al.
Publicado: (2021)

Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy
por: Nishi, Kentaro, et al.
Publicado: (2020)

Treatment of steroid-resistant pediatric nephrotic syndrome
por: Kang, Hee Gyung
Publicado: (2011)

Deflazacort in comparison to other steroids for nephrotic syndrome
por: Jat, K. R., et al.
Publicado: (2012)

Management of Steroid-Resistant Nephrotic Syndrome in Children
por: Sachdeva, Sanjana, et al.
Publicado: (2021)

Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
por: Sinha, Aditi, et al.
Publicado: (2021)

A four-drug combination therapy consisting of low-dose tacrolimus, low-dose mycophenolate mofetil, corticosteroids, and mizoribine in living donor renal transplantation: A randomized study
por: Yan, Tian-zhong, et al.
Publicado: (2016)

Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome
por: Cortazar, Frank B, et al.
Publicado: (2018)

Revised guidelines for management of steroid-sensitive nephrotic syndrome
por: Bagga, Arvind
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ofvmf10put1j2v2ostildne4q8